Dossier for Paracetamol 665mg Sustained Release will be available January 2008. Dossier is developed by Farmavita.Net memeber from Australia. Bioequvalence is carried out against Australian innovator product "Panadol Osteo". License and supply available at most competitive rates. Manufacture carried out in facilities certified by all major regularoy authorities, including TGA, MCC, MHRA, FDA and Malaysian, Singapore and Hong Kong Austhorities.
Offer is valid subject to confirmation, country by country. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights. Farmavita.Net is not owner of offered products/licenses and do not take any liability related to them. However, as the licensing agent we do our the best to facilitate that closed licensing agreements are made on mutual benefit of contracting parties and without infringement of intellectual property of third parties.